Copyright
©The Author(s) 2005.
World J Gastroenterol. Jul 28, 2005; 11(28): 4344-4350
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4344
Published online Jul 28, 2005. doi: 10.3748/wjg.v11.i28.4344
Figure 1 (PDF) Distribution of the type HBV DNA mutations in the polymerase gene.
Figure 2 (PDF) ALT of Group IA and IB.
A: ALT of Group IA: non cirrhotic patients with normal pre-treatment ALT (n = 13);B: ALT of Group IB: non-cirrhotic patients with elevated pre-treatment ALT (n = 12).
Figure 3 (PDF) ALT and CPT of Cirrhotic patients.
A: ALT of Cirrhotic patients; B: CPT of Cirrhotic patients.
- Citation: Dan YY, Wai CT, Lee YM, Sutedja DS, Seet BL, Lim SG. Outcome of lamivudine-resistant hepatitis B virus is generally benign except in cirrhotics. World J Gastroenterol 2005; 11(28): 4344-4350
- URL: https://www.wjgnet.com/1007-9327/full/v11/i28/4344.htm
- DOI: https://dx.doi.org/10.3748/wjg.v11.i28.4344